National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

MOPP regimen
A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Mustargen-Oncovin-Procarbazine-Prednisone regimen



Previous:monoclonal antibody Mik-beta-1, monoclonal antibody R24, monoclonal antibody RAV12, monoclonal antibody SGN-30, montelukast sodium
Next:Morinda citrifolia fruit extract, morphine sulfate, motesanib diphosphate, motexafin gadolinium, motexafin lutetium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov